Which Fibre, and Where It Acts

Fibre is not one nutrient. It is a spectrum defined by two independent properties, and almost every clinical win and every clinical failure comes from matching, or mismatching, the property to the patient. The first axis is viscosity, a mechanical property. Viscous fibres (beta-glucan, psyllium, guar gum, pectin, glucomannan) form a gel that slows gastric emptying, sequesters bile acids and blunts the glycaemic response. That is the cholesterol and glucose lever. The second axis is fermentability, a microbial property. Fermentable fibres (inulin, fructo-oligosaccharides, resistant starch, pectin) feed colonic bacteria and yield short-chain fatty acids. That is the microbiome and metabolic lever. The catch is that fermentation produces gas, which is exactly why “eat more fibre” backfires in the sensitive gut.

The clinically elegant exception sits between the two axes. Psyllium is highly viscous yet barely fermented. It delivers the gel benefits, cholesterol lowering, glycaemic blunting and stool normalisation, without the gas. That single property is why it is the one fibre that helps both constipation and diarrhoea, and why it is the fibre of choice in the irritable gut.

The patient in front of you this month is rarely eating too little fibre. They are eating the wrong fibre for their phenotype. Bran and inulin loaded into an irritable bowel. A lipid patient told to “eat more whole grains” when what moves LDL and ApoB is viscous soluble fibre, beta-glucan at three grams a day among them.

What this means for your next consult: stop prescribing “fibre” and start prescribing a fibre type, matched to the mechanism you are trying to move. The matrix that does that mapping is Chapter 2 of the Gut Health Handbook.

Viscosity is the metabolic lever. Viscous soluble fibres lower LDL cholesterol and ApoB without affecting HDL, and the effect tracks how viscous the fibre is. The largest current synthesis, a dose-response meta-analysis of 181 randomised trials and 14,505 participants, found soluble-fibre supplementation reduced LDL by about 8 mg/dL, roughly 0.2 mmol/L, and lowered total cholesterol and ApoB alongside it. The most viscous fibres carry the effect, and psyllium and beta-glucan each have their own dose-response analyses behind them, with konjac glucomannan supported by its own dedicated meta-analysis. The mechanism is threefold: the gel sequesters bile acids and forces the liver to draw down cholesterol to replace them; it blunts the glycaemic response and the insulin-driven hepatic cholesterol synthesis that follows; and the fermentable fraction yields propionate. Dosing is specific. The cholesterol effect for beta-glucan sits at the regulator-recognised three grams a day, divided across servings.

Fermentability is the microbiome lever. Insoluble fibres (cellulose, lignin, the bran fraction) ferment little and act mechanically, adding bulk and moving transit. Most soluble fibres ferment readily to short-chain fatty acids, with psyllium the notable low-ferment exception. Butyrate, one of those acids, is the colonocyte’s preferred fuel. The trade-off is gas, and gas is the rate-limiter on tolerance.

Two axes, independent of each other. Psyllium is the rare fibre that is high on one and low on the other.

A 44-year-old woman, irritable bowel of the mixed type, told at a previous visit to “eat more fibre.” She did. She added a wheat-bran cereal every morning and two inulin “gut” gummies a day. Three weeks on, the bloating is worse, the pain is worse, and the stool pattern is more erratic, not less.

She asks: “I did exactly what I was told. Why is it worse?”

Decision framework. She did add fibre. She added the two kinds her gut tolerates least. Insoluble bran is mechanically irritating in a hypersensitive colon and shows no symptom benefit in irritable bowel. Inulin is among the most fermentable fibres there is, which means maximal gas. The evidence is not ambiguous here. A meta-analysis of fibre in irritable bowel (14 trials, 906 patients) found benefit for soluble fibre and none for bran, and the 2021 ACG guideline suggests soluble, not insoluble, fibre for global symptoms, describing the useful kind in its own words as “soluble, viscous, poorly fermentable” fibre, which is psyllium exactly. NICE names ispaghula, the pharmaceutical name for psyllium, specifically.

Three moves, each a separate decision.

One. Stop the bran and stop the inulin.

Two. Switch to psyllium, the viscous, minimally fermented fibre that normalises stool form in both directions.

Three. Titrate slowly, with fluid, starting low and building up.

The exact starting dose, the titration cadence and the fibre-FODMAP interaction notes are in the Handbook (Chapters 2 and 5). What standard advice missed: “more fibre” was never the prescription. “Which fibre” was.

Same food group, four different prescriptions. The axis you are targeting decides the fibre.

Hypercholesterolaemia. Viscosity is the lever. Beta-glucan three grams a day divided, or psyllium; whole-food first. Pairs with the Hyperlipidaemia Handbook.

Irritable bowel. Soluble and low-ferment. Psyllium yes; bran and inulin no; titrate slowly. Pairs with the Gut Health and IBS Handbooks.

On a GLP-1 RA with constipation. Psyllium with fluid, introduced gradually so it does not compound early satiety. The lean-mass cohort from Issue 01 lands here often.

The “healthier gut” request. Fermentability and diversity. A widening range of plants plus resistant starch, built slowly to stay ahead of the gas. The microbiome play, not the lipid one.

Each archetype has its own decision tree, target and patient handout in the Gut Health Nutrition Handbook.

The summary version. Which fibre, what it does, and how strong the evidence actually is.

The patient handout for each of these sits in the Gut Health Nutrition Handbook, written for direct hand-over in the consult, so the plan leaves the room with the patient.

The fibre aisle has become a wellness category, and the feed is running ahead of the evidence. The current example is basil seeds versus chia seeds, with “which is better” content everywhere. The matrix settles it.

The whole gel-forming seeds, chia, basil and flax, are legitimate viscous fibres. Their mucilage forms a gel (chia holds many times its own weight in water) that supports satiety, blunts the glycaemic response and softens stool. Basil carries slightly more soluble fibre, chia forms the thicker gel and adds omega-3, flax sits between the two. At culinary doses the differences are small, and none matches psyllium or beta-glucan for cholesterol lowering. One honest caveat for the consult: psyllium, chia and flax have a real clinical literature, while basil seed sits mostly on food-science and social content rather than trials. Treat basil as a reasonable culinary gel-former, not an evidence-backed therapeutic. Choose by use and tolerance, not by which one went viral. And one safety line worth repeating: gel-formers must be taken with plenty of fluid and never dry.

The genuine innovation is quieter. Partially hydrolysed guar gum and acacia, also called gum arabic, are soluble, low in viscosity, slow and low-gas to ferment, and low-FODMAP. They fill the gap psyllium does not: a prebiotic the sensitive or irritable gut can actually tolerate. Partially hydrolysed guar gum has the stronger evidence base, with randomised trials in both the constipation- and diarrhoea-predominant subtypes of irritable bowel and a clean safety profile; acacia is well tolerated and slowly fermented but rests on a lighter trial base. Multi-fibre blends of the two are the current product direction.

The trap is the loud end of the aisle. Inulin and chicory-root “gut” gummies and prebiotic sodas sit in the high-fermentability, high-gas corner, the exact fibre the irritable or GLP-1 gut tolerates least, sold as the gentle option.

Same lesson as the rest of this issue. Read past the label to the axis.

The next question arriving at your consult is whether to push fibre or add fermented foods. A Stanford trial gave the first clean head-to-head.

Two things to hold now.

For the patient chasing “gut health,” the highest-yield answer is likely both: a widening range of plant fibres plus a few daily fermented servings, not fibre alone.

Personalised fibre response is the coming frontier. The same prebiotic that raises butyrate in one patient produces only gas in another, and microbiome-informed fibre selection is moving from research toward the consult. The questions arrive before the evidence does, and the clinicians who answer them well are the ones building the framework now.

Everything in this issue is the working summary. The Gut Health Nutrition Handbook is the full reference behind it: Chapter 2 (Dietary Fibre, the full viscosity-and-fermentability matrix, types, resistant starch, targets and practical titration), Chapter 4 (the GI-complaint protocols for bloating, constipation and diarrhoea), and Chapter 5 (food intolerances and the fibre-FODMAP interaction). Single-clinician licence. $89.

For an irritable-bowel-heavy caseload it pairs with the IBS Nutrition Handbook. For the lipid patient, the Hyperlipidaemia Nutrition Handbook carries the same viscous-fibre protocol in its cardiovascular context. Both sit in the bundle on the product page.

The rest of the library spans the clinical areas you work in every week, from Diabetes and GLP-1 to Menopause, Oncology, CKD and more. Each one is a single specialist topic, fully worked, with patient handouts where relevant, and bundle pricing applies on any three or more.

PS. The Fibre Matrix card below is a subscriber benefit. It is yours because you subscribe, and it is not on the public site. More subscriber-only references are on the way in future issues, so keep an eye on the Brief.

Reply with the fibre case that surprised you. The patient who got worse on “more fibre,” or the one a single switch fixed. Three sentences is enough. We are banking composites for a future issue, and identifiers never appear in the published version.

The Brief grows by word of mouth between dietitians, and the subscribers who spread it earn the library as they go. Here is how it works. Every subscriber has a personal share link, shown below. Refer two colleagues who subscribe and the Gut Health Handbook is yours, free. The rewards climb from there: the IBS Handbook at four referrals, the PMOS Handbook at six, the Diabetes Handbook at eight. No cost, no catch, just the library opening as you share.